Alkermes plc.
Recent Filings
All 1,000 filings →| Form | Description | Date |
|---|---|---|
| PRE 14A | PRE 14A | Mar 27, 2026 |
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 4, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 4, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 4, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 4, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 4, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 4, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 4, 2026 |
| 144 | — | Mar 3, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sale | 3,748 @ $30.00 | 65,740 | Dec 3, 2025 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sale | 4,000 @ $29.30 | 65,740 | Dec 1, 2025 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sale | 9,000 @ $31.53 | 73,740 | Oct 15, 2025 |
| Nichols Christian Todd | SVP, Chief Commercial Officer | Sale | 3,333 @ $31.95 | 89,542 | Jun 10, 2025 |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sale | 1,938 @ $34.00 | 7,717 | Feb 26, 2025 |
| Parisi Samuel Joseph | VP, Finance (Interim PAO) | Sale | 3,743 @ $35.26 | 7,717 | Feb 22, 2025 |
| Hopkinson Craig C. | EVP R&D, Chief Medical Officer | Sale | 33,108 @ $33.27 | 57,875 | Feb 12, 2025 |
| POPS RICHARD F | Director and CEO, Alkermes plc | Award / Grant | 190,640 | 1,370,315 | Feb 6, 2025 |
| Nichols Christian Todd | SVP, Chief Commercial Officer | Award / Grant | 24,565 | 85,268 | Feb 6, 2025 |
| Jackson Blair Curtis | EVP, Chief Operating Officer | Award / Grant | 34,393 | 192,195 | Feb 6, 2025 |